Hemgenix

Manufacturer:

CSL Behring

Name:

Hemgenix

HCPCS Code Descriptor:

Injection, etranacogene dezaparvovec-drlb, per therapeutic dose

Category:

J Code

HCPCS:

J1411

NDC(s):

0053-0480-48, 0053-0470-47, 0053-0440-44, 0053-0450-45, 0053-0460-46, 0053-0430-43, 0053-0420-42, 0053-0410-41, 0053-0350-35, 0053-0360-36, 0053-0370-37, 0053-0380-38, 0053-0390-39, 0053-0400-40, 0053-0340-34, 0053-0330-33, 0053-0320-32, 0053-0310-31, 0053-0300-30, 0053-0290-29, 0053-0250-25, 0053-0260-26, 0053-0270-27, 0053-0280-28, 0053-0240-24, 0053-0230-23, 0053-0200-20, 0053-0210-21, 0053-0220-22, 0053-0160-16, 0053-0170-17, 0053-0180-18, 0053-0190-19, 0053-0120-12, 0053-0130-13, 0053-0140-14, 0053-0150-15, 0053-0110-11, 0053-0100-10

Primary Type:

Hematology

Generic Status:

Multi-Source

Route of Administration:

Intravenous

About:

Hemgenix is a Hematology drug manufactured by CSL Behring and administered via the Intravenous route of administration. The J Code: J1411 is aligned to the drug Hemgenix.